| Literature DB >> 26288687 |
Mònica Rosa1, Gianluigi Caltabiano2, Katy Barreto-Valer3, Verónica Gonzalez-Nunez3, José C Gómez-Tamayo2, Ana Ardá4, Jesús Jiménez-Barbero4, Leonardo Pardo2, Raquel E Rodríguez3, Gemma Arsequell1, Gregorio Valencia1.
Abstract
Systematic halogenation of two native opioid peptides has shown that halogen atoms can modulate peptide-receptor interactions in different manners. First, halogens may produce a steric hindrance that reduces the binding of the peptide to the receptor. Second, chlorine, bromine, or iodine may improve peptide binding if their positive σ-hole forms a halogen bond interaction with negatively charged atoms of the protein. Lastly, the negative electrostatic potential of fluorine can interact with positively charged atoms of the protein to improve peptide binding.Entities:
Keywords: G protein-coupled receptors; Halogen bond; Leu-enkephalin; drug design; endomorphin-1; halogenated peptides; neuropeptides; opioid receptors
Year: 2015 PMID: 26288687 PMCID: PMC4538429 DOI: 10.1021/acsmedchemlett.5b00126
Source DB: PubMed Journal: ACS Med Chem Lett ISSN: 1948-5875 Impact factor: 4.345